Flare Therapeutics Funding: $287M Raised, Series C (2026)
Flare Therapeutics is based in Philadelphia. It has raised $287M in total funding. Latest round: Series C.
Flare Therapeutics funding overview
Flare Therapeutics is based in Philadelphia. Flare Therapeutics has raised $287M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series C announced in June 2026. The round record for Flare Therapeutics runs through 2026; nothing later has been disclosed. Investors on record include Third Rock Ventures, Nextech Invest, Pfizer Ventures, Boxer Capital, GordonMD Global Investments, Invus and 5 others. 11 distinct backers are named across the disclosed rounds.
Flare Therapeutics at a glance
Total raised
$287M
Latest round
Series C
Latest round date
June 2026
Headquarters
Philadelphia
Notable investors
Third Rock Ventures, Nextech Invest, Pfizer Ventures, Boxer Capital, GordonMD Global Investments, Invus, Casdin Capital, Eli Lilly and Company
Frequently asked about Flare Therapeutics funding
How much has Flare Therapeutics raised?
Flare Therapeutics has raised $287M in total disclosed funding across the rounds on record.
Who has invested in Flare Therapeutics?
Third Rock Ventures, Nextech Invest, Pfizer Ventures, Boxer Capital, GordonMD Global Investments, Invus are named among the investors backing Flare Therapeutics.
What was the latest Flare Therapeutics funding round?
The most recent disclosed round is a Series C, announced in June 2026.
Where is Flare Therapeutics based?
Flare Therapeutics is based in Philadelphia.
When did Flare Therapeutics last raise?
The last disclosed Flare Therapeutics round closed in June 2026 at Series C.
Totals shown for Flare Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Philadelphia and the investors behind them below.
